TY  - RPRT
TI  - Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines
AU  - Kumru, O.
AU  - Sanyal, M.
AU  - Friedland, N.
AU  - Hickey, J.
AU  - Joshi, R.
AU  - Weidenbacher, P.
AU  - Do, J.
AU  - Cheng, Y.-C.
AU  - Kim, P. S.
AU  - Joshi, S. B.
AU  - Volkin, D. B.
PY  - 2023
DO  - 10.1101/2023.04.03.535447
UR  - https://www.biorxiv.org/content/10.1101/2023.04.03.535447v1
ID  - 10.1101/2023.04.03.535447
ER  -